Accelerate Diagnostics, Inc. (AXDX)の価格はいくらですか

Accelerate Diagnostics, Inc. (AXDX)の価格は$0.01005です

Accelerate Diagnostics, Inc. (AXDX)の時価総額は何ですか

Accelerate Diagnostics, Inc. (AXDX)の時価総額は$146.42Kです

Accelerate Diagnostics, Inc.（AXDX）配当利回り

Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.

年	配当利回り	変化
提供された日付のデータは十分ではありません。

年

配当利回り

変化

提供された日付のデータは十分ではありません。

企業	配当利回り	国
Abbott Laboratories ABT.US	2.35%	US
Stryker Corporation SYK.US	1.07%	US
Medtronic plc MDT.US	3.69%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

企業

配当利回り

国